Usefulness of Serum N-terminal-ProBNP in Distinguishing Ascites Due to Cirrhosis From Ascites Due to Heart Failure

Journal of Clinical Gastroenterology

Volumn 44, Issue 1, 2010, Pages e23-e26

  Sheer, Todd A ^a   Joo, Elliot ^a   Runyon, Bruce A ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac ascites; Cardiac hepatopathy; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ADULT; ARTICLE; ASCITES; ASCITES FLUID; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART FAILURE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY;

ASCITES; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEART FAILURE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 75149188331     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318198113b     Document Type: Article

References (19)

1. Runyon BA. Cardiac ascites: a characterization. J Clin Gastroenterol. 1988;10:410-412.
2. Wijetunga M, Seto T, Lindsay J, et al. Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg? J Toxicol Clin Toxicol. 2003;41:981-986.
3. Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117:215-220.
4. Myers RP, Cerini R, Sayegh R, et al. Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology. 2003;37:393-400.
5. Mark D, Felker M. B-Type natriuretic peptide—a biomarker for all seasons? NEJM. 2004;350:718-720.
6. Gines P, Jimenez W, Arroyo V, et al. Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction. Hepatology. 1988;8:636-642.
7. Masson S, Latini R, Anand IS, et al. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the valsartan heart failure (Val-HeFT) data. Clin Chem. 2006;52:1528-1538.
8. Goetze JP, Kastrup J, Pedersen F, et al. Quantification of pro-B-type natriuretic peptide and its products in human plasma by an analysis independent precursor processing. Clin Chem. 2002;48:1035-1042.
9. Pfister R, Scholz M, Wielckens K, et al. Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail. 2004;6:289-293.
10. Clerico A, Fontana M, Zyw L, et al. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem. 2007;53:813-822.
11. Wong F, Siu S, Liu P, et al. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis? Clin Sci. 2001;101:621-628.
12. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2005;112:e154-e235.
13. Fuchs S, Bogomolski-Yahalom V, Paltiel O, et al. Ischemic hepatitis: clinical and laboratory observations of 34 patients. J Clin Gastroenterol. 1998;26:183-186.
14. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296:2209-2216.
15. Henriksen JH, Gotze JP, Fuglsang S, et al. Increased circulating pro-brain natriuretic peptide and brain natriuretic peptide in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut. 2003;52:1511-1517.
16. La Villa G, Romanelli RG, Raggi VC, et al. Plasma levels of brain natriuretic peptide in patients with cirrhosis. Hepatology. 1992;16:156-160.
17. Yildiz R, Yildirim B, Karincaoglu M, et al. Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol. 2005;20:1115-1120.
18. Jimenez W, Arroyo V. Origins of cardiac dysfunction in cirrhosis. Gut. 2003;52:1392-1394.
19. Dimagno EP, Corle D, O'Brien JF, et al. Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum. Mayo Clinic Proc. 1989;64:1226-1234.